We found high expression levels of AKR1C3 in a sub-group of PC bone metastases, which confirm results previously reported in castration-resistant primary prostate tumors [16], [31] and CRPC tissue of different metastatic origin [14], [15], [32]. Here, AKR1C3 is linked to pachyonychia congenita.